APOLLO TECHNOLOGY CAPITAL CORPORATION :TO NOMINATE SIX DIRECTORS TO MEDIPHARM LABS' BOARD
APOLLO: TOGETHER WITH ITS AFFILIATES AND ASSOCIATES COLLECTIVELY OWN ABOUT 3.0% OF MEDIPHARM STOCK
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.